AIA-360 Automated Immunoassay Analyzer, Product Code 019945

FDA Device Recall #Z-1420-2020 — Class II — January 10, 2020

Recall Summary

Recall Number Z-1420-2020
Classification Class II — Moderate risk
Date Initiated January 10, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Tosoh Bioscience Inc
Location Grove City, OH
Product Type Devices
Quantity 12

Product Description

AIA-360 Automated Immunoassay Analyzer, Product Code 019945

Reason for Recall

A display screen software issue on the analyzer causes the display to freeze when display screen is touched at the same time as a command from the instrument firmware, causing the instrument to stop. As a result, the run is aborted and the results are not retrievable.

Distribution Pattern

Distributed to AZ, NE, NJ, NY, and WA. Foreign distribution to Cayman Islands, Costa Rica, and Uruguay

Lot / Code Information

28469102 28629205 28469202 28629305 28469302 28629405 28469402 28629505 28469502 28629605 28469602 28629705 28469702 28709907 28469802 28719007 28469902 28719107 28479002 28719207 28519303 28719307 28519403 28719407 28519503 28719507 28519603 28719607 28519703 28719707 28519803 28719807 28519903 28719907 28529003 28729007 28529103 28729108 28529203 28729208 28529903 28729308 28539003 28729408 28539103 28729508 28539203 28729608 28539303 28759908 28539403 28769008 28539503 28769108 28539603 28769208 28539703 28769308 28539803 28769408

Other Recalls from Tosoh Bioscience Inc

Recall # Classification Product Date
Z-2968-2020 Class II Tosoh Bioscience AIA-PACK BHCG Calibration Veri... Aug 7, 2020
Z-2967-2020 Class II Tosoh Bioscience AIA- PACK HCG Calibrator Set-I... Aug 7, 2020
Z-2423-2020 Class II AIA-900 Analyzer, Part no. 022930, UDI 04560189... May 22, 2020
Z-0675-2019 Class II ST AIA-PACK Homocysteine (HCY) is designed for ... Nov 30, 2018
Z-0676-2019 Class II ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hor... Nov 30, 2018

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.